A new project led by Dr. Brandon Guthrie, assistant professor of global health and epidemiology at the University of Washington School of Public Health, has received a two-year, $350,000 grant from Gilead Sciences to help achieve micro-elimination of hepatitis C in parts of Kenya.
Micro-elimination focuses on breaking down national and international elimination goals into smaller goals that are relevant for defined populations. To support micro-elimination efforts, the Gilead Medical Affairs team has funded up to 30 projects around the world.
“We believe rapid action is needed to prevent and treat hepatitis C virus among persons who inject drugs in Kenya, particularly those co-infected with HIV,” said Dr. Guthrie, who is also an alum of the School. “The hepatitis C virus is a major threat to the health of this highly vulnerable and marginalized population, and can spread explosively without intervention.”Friday Letter Submission